Publications

5803 Results

Clinical benefit of Imatinib in patients (pts) with metastatic gastrointestinal stromal tumors (GIST) negative for the expression of CD117 in the S0033 trial.

Authors
ME Blackstein;C Rankin;C Fletcher;M Heinrich;R Benjamin;M von Mehren;C Blanke;JA Fletcher;E Borden;G Demetri
Journal / Conference
Proc of the ASCO, JCO 23(16S):818s (#9010)
Year
2005
Research Committee(s)
Sarcoma
Study Number(s)
S0033

Incidence and reasons for dose modification of standard-dose vs. high-dose imatinib mesylate (IM) in the phase III intergroup study S0033 of patients (pts) with unresectable or metastatic gastrointestinal stromal tumor (GIST)

Authors
P Dileo;CJ Rankin;RS Benjamin;M von Mehren;C Blanke;V Bramwell;R Maki;C Fletcher;EC Borden;GD Demetri
Journal / Conference
Proc of the ASCO, JCO 23(16S):824s (#9032)
Year
2005
Research Committee(s)
Sarcoma
Study Number(s)
S0033

SWOG S0102: a phase II study of docetaxel (DOC) and vinorelbine (VNR) + filgrastim for HER-2 negative, stage IV breast cancer

Authors
J Gralow;S Green;D Lew;W Barlow;KA Dammann;G Somlo;S Rivkin;S Taylor;L Wong;R Livingston
Journal / Conference
Proc of the ASCO, JCO 23(16S):20s (#567)
Year
2005
Research Committee(s)
Breast
Study Number(s)
S0102

Phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin's lymphoma (NHL): Southwest Oncology Group study S0108

Authors
AT Stopeck;W Bellamy;JM Unger;L Rimsza;M Iannone;RI Fisher;TP Miller
Journal / Conference
Proc of the ASCO, JCO 23(16S):583s (#6592)
Year
2005
Research Committee(s)
Lymphoma
Study Number(s)
S0108

Increased EGFR gene copy number detected by fish is associated with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma (BAC) (S0126)

Authors
FR Hirsch;DR Gandara;J McCoy;J Crowley;HJ West;PH Gumerlock;PA Bunn;WA Franklin;M Varella-Garcia
Journal / Conference
Proc of the ASCO, JCO 23(16S):628s (#7030)
Year
2005
Research Committee(s)
Lung
Study Number(s)
S0126

The proteasome inhibitor PS-341 (bortezemib) in platinum (plat)-treated extensive-stage small cell lung cancer (E-SCLC): a SWOG (0327) phase II trial

Authors
J Johl;K Chansky;PN Lara;AM Davies;R Bold;DR Gandara
Journal / Conference
Proc of the ASCO, JCO 23(16S):632s (#7047)
Year
2005
Research Committee(s)
Lung
Study Number(s)
S0327

The clinical spectrum of adult acute myeloid leukemia (AML) associated with core binding factor (CBF) translocations

Authors
FR Appelbaum;KJ Kopecky;ML Slovak;HM Gundacker;M Tallman;H Kim;GW Dewald;E Estey;H Kantarjian;S Pierce
Journal / Conference
Proc of the ASCO, JCO 23(16S):563s (#6513)
Year
2005
Research Committee(s)
Leukemia

Phase III Southwest Oncology Group 9415/ Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer

Authors
EA Poplin;JK Benedetti;NC Estes;DG Haller;RJ Mayer;RM Goldberg;GR Weiss;SE Rivkin;JS Macdonald
Journal / Conference
Journal of Clinical Oncology 23(9):1819-1825
Year
2005
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)

Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma

Authors
K Chansky;J Benedetti;JS Macdonald
Journal / Conference
Cancer 103(6):1165-1171
Year
2005
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8572, SWOG-8591(NCI Intergroup #0035), SWOG-8611, SWOG-8905

Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma: a Southwest Oncology Group study

Authors
UN Vaishampayan;JR Faulkner;EJ Small;BG Redman;WL Keiser;DP Petrylak;ED Crawford
Journal / Conference
Cancer 104(8):1627-1632
Year
2005
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9457